<h4>Background</h4>Prostate cancer (PCa) is prototypically immunologically "cold", characterized by low tumor mutational burden, sparse CD8<sup>+</sup> T-cell infiltration, and resistance to immune checkpoint blockade. The gene discussed is CD8A; the disease is neoplasm.